Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

OX40, Venetoclax, Avelumab, Glasdegib, Gemtuzumab Ozogamicin, and Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia

M.D. Anderson Cancer Center · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
recurrent acute myeloid leukemia, refractory acute myeloid leukemia, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1008510
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.